Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in IntangiblesChange in InventoryGains from Investment SecuritiesNet Debt Issuances and RepaymentsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Net Cash Flow: 2022-2023

Historic Net Cash Flow for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$1.5 million.

  • Mainz Biomed N.V's Net Cash Flow rose 70.00% to -$1.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$9.6 million, marking a year-over-year decrease of 212.87%. This contributed to the annual value of -$689,199 for FY2024, which is 92.83% up from last year.
  • Per Mainz Biomed N.V's latest filing, its Net Cash Flow stood at -$1.5 million for Q4 2023, which was up 29.20% from -$2.0 million recorded in Q3 2023.
  • Mainz Biomed N.V's 5-year Net Cash Flow high stood at $21.3 million for Q1 2022, and its period low was -$6.3 million during Q1 2023.
  • For the 2-year period, Mainz Biomed N.V's Net Cash Flow averaged around -$136,956, with its median value being -$3.0 million (2022).
  • Within the past 5 years, the most significant YoY rise in Mainz Biomed N.V's Net Cash Flow was 104.54% (2023), while the steepest drop was 129.55% (2023).
  • Over the past 2 years, Mainz Biomed N.V's Net Cash Flow (Quarterly) stood at -$4.8 million in 2022, then skyrocketed by 70.00% to -$1.5 million in 2023.
  • Its Net Cash Flow was -$1.5 million in Q4 2023, compared to -$2.0 million in Q3 2023 and $176,664 in Q2 2023.